DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7KNZ3

Market Closed - Börse Stuttgart 11:58:26 2024-05-31 am EDT
180.4 EUR +0.04% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month-0.77%
1 month-0.77%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 180.4 +0.04%
24-05-30 180.4 -0.11%
24-05-29 180.5 +0.42%
24-05-28 179.8 +0.03%
24-05-27 179.7 -0.27%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 11:58 am EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7KNZ
ISINDE000ME7KNZ3
Date issued 2024-01-25
Maturity 2024-09-20 (112 Days)
Parity 1 : 1
Emission price 178.7
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 182.2
Lowest since issue 174.1
Spread 0.08
Spread %0.04%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus